Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
SZSE:002864.SZ
36.39 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||
Net Income
| 111.545 | 103.147 | 94.557 | 81.092 | 71.779 | 64.682 | 43.719 | 39.58 | 42.697 | 38.897 | 32.894 |
Depreciation & Amortization
| 31.049 | 18.307 | 16.85 | 14.451 | 13.179 | 11.832 | 11.342 | 8.267 | 7.596 | 5.887 | 37.59 |
Deferred Income Tax
| 3.536 | 1.218 | -3.236 | -1.981 | -0.582 | -0.136 | -3.146 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 1.955 | 1.694 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -52.263 | -16.636 | -4.567 | -5.741 | -14.344 | -21.209 | -27.148 | 12.762 | -11.099 | -0.654 | 0 |
Accounts Receivables
| -46.142 | -94.416 | -56.675 | -38.961 | -41.411 | -28.128 | -56.783 | -11.8 | 0 | 0 | 0 |
Inventory
| 4.973 | -28.104 | -0.465 | 2.065 | -19.568 | -7.939 | -3.29 | 1.214 | -0.028 | 1.896 | 0 |
Accounts Payables
| -14.631 | 104.666 | 55.808 | 33.136 | 47.216 | 14.994 | 36.072 | 0 | 0 | 0 | 0 |
Other Working Capital
| 1.955 | 1.218 | -3.236 | -1.981 | -0.582 | -13.27 | -23.858 | 11.548 | -11.071 | -2.55 | 0 |
Other Non Cash Items
| 4.673 | 17.632 | 9.196 | 2.436 | -2.727 | -8.458 | 0.536 | 1.383 | 1.427 | 4.425 | -32.894 |
Operating Cash Flow
| 104.048 | 125.362 | 116.036 | 92.238 | 67.887 | 46.846 | 28.449 | 61.991 | 40.621 | 48.555 | 25.434 |
Investing Activities: | |||||||||||
Investments In Property Plant And Equipment
| -62.513 | -55.836 | -80.677 | -71.18 | -33.551 | -20.063 | -23.448 | -17.056 | -45.078 | -32.424 | -30.551 |
Acquisitions Net
| -7.99 | 0.177 | -5.1 | -1.911 | 0.895 | -0 | 0.983 | 0.15 | 0 | 0 | 0 |
Purchases Of Investments
| -2.61 | -10 | 0 | -420 | -581 | -550 | 0 | -0.655 | 0 | -11.01 | 0 |
Sales Maturities Of Investments
| 10.578 | -0.177 | 0 | 662.751 | 586.497 | 325.643 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| -8.017 | 28.266 | 0.029 | 0.177 | 0.5 | -2.255 | 2.955 | 7.25 | 1.2 | 13.811 | -3.246 |
Investing Cash Flow
| -62.41 | -37.57 | -85.748 | 169.837 | -26.659 | -246.676 | -20.493 | -10.461 | -43.878 | -29.623 | -33.798 |
Financing Activities: | |||||||||||
Debt Repayment
| -32.775 | -103 | -9.994 | -57.686 | 0 | -3 | -20 | -20 | -40 | -20 | -19 |
Common Stock Issued
| 0 | 0 | 10.102 | 20.047 | 0 | -4.852 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| -0.056 | 0 | -10.102 | -20.047 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -19.329 | -15.398 | -12.829 | -13 | -8.667 | -8.667 | -0.359 | -1.345 | -1.389 | -1.59 | -1.803 |
Other Financing Activities
| 294.004 | 440.433 | 34.899 | 76.45 | 0 | -7.852 | 188.205 | 15 | 20 | 40 | 20.061 |
Financing Cash Flow
| 236.931 | 316.347 | 7.015 | 2.244 | -8.667 | -16.519 | 167.846 | -6.345 | -21.389 | 18.41 | -0.743 |
Other Information: | |||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 |
Net Change In Cash
| 278.569 | 404.139 | 37.302 | 264.319 | 32.56 | -216.349 | 175.802 | 45.186 | -24.647 | 37.343 | -9.107 |
Cash At End Of Period
| 1,102.013 | 823.444 | 419.305 | 382.003 | 117.684 | 85.123 | 301.472 | 125.67 | 80.484 | 105.13 | 67.788 |